[if gte mso 9] > < xml >
30 may: World multiple sclerosis day
-this chronic disease affects two million people inworldwide, some 46,000 in Spain
– manifests mainly between 20 and 40 years of age,being the leading cause of non-traumatic disability among young adults inSpain
-in new treatments and stem cell researchIt is a hope for those affected who see cuts to theresearch, a brake in the handling of this incurable disease
Madrid, 2012-may on the occasion of the world day of theMultiple sclerosis, which is celebrated on May 30, the Spanish Association ofMultiple sclerosis (AEDEM-COCEMFE), Member entity of COCEMFE, held a human cord ” at its headquarters, located in c / Sanxenxo, 36 of Madrid Wednesday 30may at 12: 00 pm, with the slogan join the research of theMultiple sclerosis ”. Any person may accede virtually the day toThis cord on the http://www.aedem.org/ page. This event will take place simultaneously in the adhered entities toAEDEM-COCEMFE across national territory.
this activity is to draw attention to thisdemyelinating neurodegenerative disease and Chronicle of the nervous systemCentral that affects two million people in the world. There are currently nocure for multiple sclerosis, only there are treatments which modifyits course, delaying their effects in time.
AEDEM-COCEMFE requested greater involvement of thepublic administrations in the research of this disease. In addition,considers it essential to put an end to the delay in the administration of thetreatments, since the doctor proposes a change in medication until thethe same administration. He claims also that social cuts notaffect the maintenance of the associative fabric, as well as the recognition of the33% of disability associated with the diagnosis to support the return to workand social.
AEDEM-COCEMFE has as main objective to improve thequality of life of the people affected by multiple sclerosis as well as ofmembers of their families.It belongs to COCEMFE and isfull member of the International Federation of multiple sclerosis(MSIF) and the European platform of multiple sclerosis (PMSCS).